EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

The efficacy of a regimen comprising clarithromycin, clofazimine, and bedaquiline in a mouse model of chronic Mycobacterium avium lung infection

Binayak Rimal, Ruth A Howe, Chandra Panthi, Gyanu Lamichhane iD

Antimicrobial Agents and Chemotherapy · 2025

DOI: 10.1128/aac.01853-24 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Antimicrobial Agents and Chemotherapy, 2025. Verfasst von Binayak Rimal und 3 weiteren Autor:innen. Beteiligte Einrichtung: Division of Infectious Diseases, Department of Medicine, School of Medicine, Johns Hopkins University, Baltimore, Maryland, USA. Hauptthemen laut MEDLINE: Clofazimine, Clarithromycin, Diarylquinolines, Anti-Bacterial Agents. Die Arbeit wurde bisher 12-mal zitiert (Crossref) und nennt 29 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIAID NIH HHS, NIH HHS, National Institutes of Health.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Mycobacterium avium, a leading nontuberculous mycobacterium (NTM) pathogen, causes chronic pulmonary infections, particularly in individuals with underlying lung conditions or immunosuppression. Current treatments involve prolonged multidrug regimens with poor outcomes and significant side effects, highlighting the urgent need for improved therapies. Using a BALB/c mouse model of chronic M. avium pulmonary disease, we evaluated the efficacy of individual antibiotics—clarithromycin, clofazimine, and rifabutin—and combination regimens including clarithromycin + bedaquiline and clarithromycin + clofazimine + bedaquiline. Clarithromycin demonstrated potent bactericidal activity, reducing lung bacterial burden by 2.2 log 10 CFU, while clofazimine transitioned from bacteriostatic to bactericidal, achieving a 1.7 log 10 CFU reduction. Rifabutin was bacteriostatic against M. avium MAC 101 but ineffective against MAC 104. The triple-drug regimen of clarithromycin + clofazimine + bedaquiline was the most effective, achieving a 3.3 log 10 CFU reduction in bacterial load, with 98% clearance within the first week and continued efficacy over 8 weeks. Gross pathology confirmed these results, with granulomatous lesions observed only in untreated or rifabutin-treated mice. Combination therapy demonstrated enhanced efficacy compared to monotherapy. The findings underscore the potential of oral clarithromycin + clofazimine + bedaquiline or clarithromycin + clofazimine regimen as a promising therapeutic strategy for M. avium pulmonary disease.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

ClofazimineClarithromycinDiarylquinolinesAnti-Bacterial AgentsMycobacterium aviumMycobacterium avium-intracellulare InfectionAnimalsMiceMice, Inbred BALB CRifabutinDrug Therapy, CombinationLungDisease Models, AnimalFemaleMicrobial Sensitivity Tests

Stichwörter der Autor:innen

Mycobacterium aviumbedaquilineclarithromycinclofaziminemouse model

Substanzen

ClofazimineClarithromycinbedaquilineDiarylquinolinesAnti-Bacterial AgentsRifabutin

Autor:innen und Institutionen

  • Division of Infectious Diseases, Department of Medicine, School of Medicine, Johns Hopkins University, Baltimore, Maryland, USA.
  • Center for Nontuberculous Mycobacteria and Bronchiectasis, School of Medicine, Johns Hopkins University, Baltimore, Maryland, USA.

ORCID-Profile: Gyanu Lamichhane

Förderung

  • NIAID NIH HHS
  • NIH HHS
  • National Institutes of Health

Zitieren

APA

Rimal, B., Howe, R. A., Panthi, C., & Lamichhane, G. (2025). The efficacy of a regimen comprising clarithromycin, clofazimine, and bedaquiline in a mouse model of chronic Mycobacterium avium lung infection. Antimicrobial Agents and Chemotherapy. https://doi.org/10.1128/aac.01853-24

Vancouver

Rimal B, Howe RA, Panthi C, Lamichhane G. The efficacy of a regimen comprising clarithromycin, clofazimine, and bedaquiline in a mouse model of chronic Mycobacterium avium lung infection. Antimicrobial Agents and Chemotherapy. 2025. doi:10.1128/aac.01853-24

BibTeX
@article{Rimal2025,
  author = {Rimal, Binayak and Howe, Ruth A and Panthi, Chandra and Lamichhane, Gyanu},
  title = {The efficacy of a regimen comprising clarithromycin, clofazimine, and bedaquiline in a mouse model of chronic Mycobacterium avium lung infection},
  journal = {Antimicrobial Agents and Chemotherapy},
  year = {2025},
  doi = {10.1128/aac.01853-24}
}
Kostenlos starten →